Clinical Trial Update: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Brilacidin for serious skin infections completed with results on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Skin Infection

Drugs mentioned

• Brilacidin

Snippet

Sponsor: Cellceutix Corporation | Conditions: Skin Infection, Bacterial Infection | Phase 2 | Status: COMPLETED